drugset / Trial / NCT00352482

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

NCT00352482

RandomizedCrossoverDouble-blindTreatment

Summary

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that affects an individual's ability to breathe. Currently, no medications can reverse the damage to the lungs caused by IPF, but individuals are encouraged to engage in moderate exercise to strengthen lung function. This study will evaluate the effectiveness of sildenafil at improving exercise tolerance and breathing difficulties in individuals with IPF.

Timeline

Start
2004-11
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg